Share Email Print

Proceedings Paper

980nm laser for difficult-to-treat basal cell carcinoma
Author(s): A. D. Derjabo; I. Cema; I. Lihacova; L. Derjabo
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Begin basal cell carcinoma (BCC) is most common skin cancer over the world. There are around 20 modalities for BCC treatment. Laser surgery is uncommon option. We demonstrate our long term follow up results. Aim: To evaluate long term efficacy of a 980nm diode laser for the difficult-to-treat basal cell carcinoma. Materials and Methods: 167 patients with 173 basal cell carcinoma on the nose were treated with a 980 nm diode laser from May 1999 till May 2005 at Latvian Oncology center. All tumors were morphologically confirmed. 156 patients were followed for more than 5 years. Results: The lowest recurrence rate was observed in cases of superficial BCC, diameter<6mm; bet the highest recurrence rate was in cases of infiltrative BCC and nodular recurrent BCC. Conclusions: 980 nm diode laser is useful tool in dermatology with high long term efficacy, good acceptance by the patients and good cosmetics results.

Paper Details

Date Published: 24 June 2013
PDF: 7 pages
Proc. SPIE 8803, Medical Laser Applications and Laser-Tissue Interactions VI, 88030B (24 June 2013); doi: 10.1117/12.2031532
Show Author Affiliations
A. D. Derjabo, Latvian Oncology Ctr. (Latvia)
Riga Stradinš Univ. (Latvia)
I. Cema, Latvian Oncology Ctr. (Latvia)
Riga Stradinš Univ. (Latvia)
I. Lihacova, Univ. of Latvia (Latvia)
L. Derjabo, Univ. of Latvia (Latvia)

Published in SPIE Proceedings Vol. 8803:
Medical Laser Applications and Laser-Tissue Interactions VI
Lothar D. Lilge; Ronald Sroka, Editor(s)

© SPIE. Terms of Use
Back to Top